Berberine Moringa NAD+ Patches Gaining Consumer Interest: Guide to Transdermal Supplement Delivery vs. Capsules

Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine FormatsSAN LEANDRO, CA, Jan. 15, 2026 (GLOBE ...
Nasdaq

Nutriband Inc. Expands U.S. Patent Protection for AVERSA™ Transdermal Abuse Deterrent Technology

Issuance of a new patent strengthens Nutriband's intellectual property protection for its AVERSA™ transdermal abuse deterrent technology in the United States. The technology potentially addresses ...
Nasdaq

Nutriband Inc. Receives USPTO Notice of Allowance for Aversa™ Abuse Deterrent Transdermal Technology Patent

Nutriband Inc. announced it has received a Notice of Allowance from the USPTO for its patent application regarding the Aversa™ abuse deterrent technology, which is designed to prevent the misuse and ...
Business Insider

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced ...
Seeking Alpha

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Nutriband (NTRB) files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for ...
WGN Radio

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA™ abuse deterrent transdermal technology ...